Asparagus

Asparagus (Asparagus officinalis L.): A Comprehensive Reference

1. Identity, Taxonomy, and Botanical Description

Scientific name: Asparagus officinalis L. Common name: Garden asparagus. In the Linnean classification, asparagus was formerly placed in the lily family, with leeks, onions, and garlic, but more recently it has been reassigned to the Asparagaceae family, the Asparagoideae subfamily, and the Asparagus genus of about 300 species. Of these, Asparagus officinalis is the one consumed in most parts of the world.

Asparagus is a dioecious, perennial herb native to Europe and Asia and is widely cultivated. It has scale-like leaves and an erect, multibranched stem that grows up to 3 m in height. The aerial stems or spears arising from rhizomes are consumed as a vegetable. Its grey-green, feathery cladodes (modified stems) replace true leaves, forming tufts atop slender, erect stems. Clusters of tiny bell-shaped white to greenish flowers appear in spring, followed by red berries in autumn.

The term "asparagus root extract powder" is not a single, universally defined botanical ingredient. In commercial products and health content, the term may refer to Asparagus officinalis, Asparagus racemosus (shatavari), or Asparagus cochinchinensis. Because these species differ in phytochemistry, traditional use, and research support, the most important first step is confirming botanical identity before evaluating benefits, safety, or formulation value.

Common Forms and Preparations

• Fresh or cooked spears: The most common form worldwide, consumed as a food vegetable.
• Dried root powder: The fleshy roots and, to a lesser degree, seeds have been used for medicinal purposes.
• Standardized root extract tablets: The commercial product Asparagus-P contains 200 mg of pulverized dried asparagus root and 200 mg of dried parsley leaves per tablet.
• Aqueous and ethanol extracts: Used extensively in preclinical research from both shoots and leaves.
• Instant asparagus powder: A processed form evaluated in some human food studies.
• Topical preparations: Home remedies have included topical application of preparations containing the shoots and extracts to cleanse the face and dry acneform lesions.

2. Traditional and Historical Use

Images of asparagus are present on Egyptian sarcophagi from 5000 years ago. Cato the Elder (d. 149 BC) recorded asparagus in De agri cultura as the only vegetable next to cabbage worth growing. Columella, in the first century AD, wrote that the Romans preserved asparagus in its own sauce and ate it hot with melted butter, salt, pepper and a dash of lemon.

Archaeological digs in Crete and Egypt uncovered Asparagus officinalis remains dating back to 3000 BCE, indicating its culinary and medicinal roles even in pharaonic times. Ancient Greek physicians like Hippocrates noted its mild diuretic properties, and Roman texts (Pliny the Elder) praised its quick growth and digestive benefits.

In various civilizations, asparagus also played an important role as an aphrodisiac. It is also used as an ornamental and medicinal plant. In Eastern Europe and Asia, decoctions of rhizomes and asparagus roots have long been used for the treatment of cardiovascular diseases, rheumatism, and epilepsy.

As a traditional Chinese herb according to the famous medical book "Compendium of Materia Medica," asparagus contains a variety of bioactive phytochemicals, including bioactive polysaccharides, steroidal saponins, flavonoids, dietary fibre, and bioactive oligosaccharides.

Asparagus cochinchinensis — a related Asian species — was first documented in Shennong's Classic of Materia Medica (Dong Han Dynasty, 25–220 AD), which is the earliest classic on Traditional Chinese Medicine. Later, it was listed in many other well-known works on Chinese herbs, including "Ming Yi Bie Lu" (Wei and Jin Dynasty, 220–420 AD) and "Yao Xing Lun" (Tang Dynasty, 618–907 AD).

Ayurvedic traditions use primarily the young shoots (spears) and dried root powder, prized for balancing Vata and Kapha doshas. It must not be confused with Asparagus racemosus, a distinct plant used prominently in Ayurvedic medicine.

Regarding the distinctive urinary odor associated with asparagus: In 1702 the French botanist and chemist Louis Lémery wrote that asparagus spears "cause a filthy and disagreeable smell in the urine, as everybody knows." In 1781 Benjamin Franklin wrote that "a few stems of asparagus eaten shall give our urine a disagreeable odor" and hoped that scientists would discover a drug to render this as agreeable as perfumes.

3. Key Constituents and Active Compounds

3.1 Steroidal Saponins

The literature survey has revealed that the steroidal saponins are the main biologically active constituents of the genus Asparagus. There is a wide disparity in the structures of bioactive compounds ranging from sulfur-containing carboxylic acids, chalcones, steroidal sapogenins, and saponins. The main saponins present in white and green A. officinalis are asparanin, protodioscin, yamogenin, and sarsasapogenin. A. officinalis also contains various steroid saponins, including asparagosides A, B, D, F, H, and I, and the bitter steroid saponins.

Two glycoside bitter principles, officinalisins I and II, were isolated from dried roots in yields of 0.12% and 0.075%. Other root components are beta-sitosterol, steroidal glycosides (asparagosides A to I, in order of increasing polarity), and steroidal saponins.

3.2 Flavonoids and Phenolic Compounds

One important flavonoid was rutin, representing 60–80% of the total phenolic compound content of purple and green asparagus extracts; for example, 1.51–7.29 mg/g dry weight for green asparagus, and below 0.5 mg/g dry weight for white asparagus. Tsushida et al. (1994) reported that 75% of the antioxidant activity of asparagus is derived from rutin.

Rutin is a glycoside hydrolyzed into aglycone and quercetin by enzymes in the human gut microbiota. Rutin has been shown to improve colitis, modulate the signaling of tumor necrosis factor-alpha and nuclear factor kappa B activity, reduce myeloperoxidase activity, and modulate the levels of proinflammatory cytokines.

A wider array of bioactive compounds, including rutin (211.3 mg/100 g extract), quercetin (7.0 mg/100 g extract), L-asparagine (3.7 mg/100 g extract), caffeic acid (12.0 mg/100 g extract), ferulic acid (5.9 mg/100 g extract), and inosine (5.3 mg/100 g extract), were characterized in A. officinalis roots by HPLC and NMR.

A transcriptome analysis using HPLC showed that the rutin content is higher in green asparagus, while the protodioscin content is higher in white asparagus. Asparagus spears are known to contain a large amount of rutin, which has been found to possess anti-inflammatory, antitumor, and antibacterial/viral properties, and protodioscin, which is an antitumor substance, present in the bottom parts (8 cm from the cut end).

3.3 Inulin-Type Fructans and Oligosaccharides

Asparagus roots contain inulin and several fructo-oligosaccharides. Fructans from asparagus roots contain polymers of up to 25 sugar units, and a variety of iso-isomers have been identified. As dietary fibers, natural inulin-type fructans are indigestible by human digestive enzymes. Intensive evidence has clearly shown that inulin-type fructans are digested by gut microbiota and have prebiotic abilities to stimulate probiotic growth and to produce beneficial short-chain fatty acids (SCFAs) in both healthy and diseased conditions.

3.4 Vitamins and Micronutrients

Asparagus contains large amounts of folic acid (10 cooked shoots provide 225 micrograms, or almost 50% of the daily requirement) and vitamin C (10 cooked shoots provide 25 mg). Asparagus is also a good source of dietary fiber, vitamin E, vitamin B6, and several minerals.

3.5 Sulfur Compounds

Asparagus contains asparagusic acid, an odorless sulfurous compound that is metabolized in the body into sulfur-containing compounds such as methanethiol and dimethyl sulfide. Eating asparagus can give a characteristic odour to the urine, due to the breakdown of compounds containing sulphur. However, not all people produce this smell, and people also vary in their ability to detect it.

3.6 Anthocyanins

Among different species, purple asparagus compared to white asparagus and green asparagus is higher in anthocyanin, which is expected to have a higher antioxidant activity than other asparagus varieties. However, the green asparagus spears also contain anthocyanin, which therefore often takes on a red tinge.

3.7 Amino Acids

The genus name of asparagus is also the source of the amino acid asparagine, which was first isolated from asparagus juice in 1806 and is one of the 20 most common natural amino acids. Chemical constituents of Asparagus officinalis include glycosides, flavonoids, and the amino acid asparagine. The amino acid and inorganic mineral contents were found to be much higher in the leaves than the shoots.

4. Proposed Mechanisms of Action

Asparagus species possess a variety of biological properties, such as being antioxidants, immunostimulants, anti-inflammatory, antihepatotoxic, antibacterial, antioxytocic, and reproductive agents. The major proposed mechanisms underlying these properties include:

• Antioxidant activity: Treatment of HepG2 human hepatoma cells with the leaf extract suppressed more than 70% of the intensity of hydrogen peroxide (1 mM)-stimulated DCF fluorescence, a marker of reactive oxygen species (ROS).
• Enzyme modulation for ethanol metabolism: The activities of two key enzymes that metabolize ethanol, alcohol dehydrogenase and aldehyde dehydrogenase, were upregulated by more than 2-fold in response to treatment with the leaf- and shoot extracts.
• ACE inhibition and diuresis: Although data are weak regarding asparagus' antihypertensive effects, it is believed to lower blood pressure through its diuretic and/or angiotensin-converting enzyme (ACE)–inhibitory effects.
• Insulin secretion and beta-cell function: Hafizur et al. reported that A. officinalis extract exhibited antidiabetic effects by improving insulin secretion and β-cell function as well as antioxidant status, similar to those of glibenclamide in streptozotocin-induced diabetic rats.
• Anti-inflammatory signaling: Rutin has been shown to improve colitis, modulate the signaling of tumor necrosis factor-alpha and nuclear factor kappa B activity, reduce myeloperoxidase activity, and modulate the levels of proinflammatory cytokines.
• Prebiotic fermentation: Asparagus-derived fructans, similar to commercial fructans, promote beneficial bacterial growth. Despite having a lower degree of polymerization (DP up to 25), they undergo microbial fermentation, supporting gut balance and SCFA production.
• Anticancer signaling: Asparagus officinalis decreased cellular viability, caused cell cycle G1 phase arrest, and induced apoptosis in ovarian cancer cell lines. Induction of apoptosis and inhibition of cell proliferation was rescued by the pan-caspase inhibitor Z-VAD-FMK, implying that its cytotoxic effects were mainly dependent on caspase pathways.

5. Scientific Evidence by Area of Use

It is important to note upfront that asparagus has been studied for its diuretic, hypoglycemic, antihypertensive, hypocholesterolemic, CNS, and antioxidant effects; however, there is little to no clinical evidence to support these uses. The majority of evidence remains preclinical (animal and cell-based). Each area is described below with the type and strength of evidence available.

5.1 Diuretic Effects

Modern studies have shown asparagus to have a diuretic effect and promote defecation; it also demonstrates high levels of basic nutrients, including vitamins, amino acids, and mineral salts, and it is also rich in fiber. Roots and seeds have been used as a treatment for various illnesses and as a diuretic, despite the lack of clinical evidence.

One human observational study examined a standardized asparagus root preparation. Asparagus-P, administered as 4 tablets 3 times/day (maximum dosage of 2,400 mg daily of dried asparagus root) for a target of 6 weeks, was evaluated for its antihypertensive effects; however, adverse reactions led to participant withdrawal from the study. Evidence strength: Preliminary/weak. Mechanistic rationale supported by traditional use; controlled human trial evidence is lacking or inconclusive.

5.2 Blood Pressure and Cardiovascular Effects

Asparagus also had positive effects in treating hypertension from human clinical trials, which could be used as an antihypertensive agent (Chrubasik, Droste, Dragano, Glimm, & Black, 2006). However, a subsequent study found that Asparagus P® cannot compete with first-line diuretics in lowering the blood pressure in treatment-requiring antihypertensives (Phytother Res 2009).

In animal work, a 10-week study of spontaneously hypertensive rats found that dietary consumption of asparagus at 5% lowered systolic blood pressure, urinary protein excretion, and ACE activity compared with a normal diet. Rutin has anti-inflammatory and antihypertensive effects in animal experiments, and biological effects such as suppression of capillary weakness in humans.

Evidence strength: Mixed and weak for clinical use. One small human pilot study suggested modest antihypertensive effects, while a follow-up study found it inferior to standard diuretics. Preclinical (animal) evidence is more consistent.

5.3 Glycemic Control and Antidiabetic Effects

Zhao et al. studied the hypoglycemic effect of the aqueous extract of A. officinalis by-products in a streptozotocin-induced diabetic rat model. Supplementation for 21 days significantly decreased serum glucose and triglyceride concentrations but increased hepatic glycogen concentration and body weight in diabetic rats.

Hafizur et al. found A. officinalis seed extract to have anti-diabetic effects in non-obese type 2 diabetic rats supplemented with 250 and 500 mg/kg extract each day for 28 days; however, a particularly significant improvement was found for the 500 mg/kg dose, which was associated with an increase in insulin secretion. The authors also noted that 0.5 mg/mL A. officinalis extract demonstrated 87% DPPH radical-scavenging activity in vitro, but only 32% inhibition of α-glucosidase in vitro. This result may suggest that the used extract has very little effect on delaying glucose absorption.

Rutin has also been reported to exert antidiabetic effects by suppressing intestinal carbohydrate absorption, reducing glucose production, increasing tissue glucose intake, and stimulating pancreatic insulin secretion.

Evidence strength: Preclinical (animal) only. No adequately powered human clinical trials have confirmed antidiabetic efficacy of A. officinalis extracts. Evidence is preliminary and cannot be extrapolated to humans.

5.4 Liver Protection (Hepatoprotective Effects)

Cellular toxicities induced by treatment with hydrogen peroxide, ethanol, or tetrachloride carbon (CCl4) were significantly alleviated in response to treatment with the extracts of A. officinalis leaves and shoots. Additionally, the activities of two key enzymes that metabolize ethanol, alcohol dehydrogenase and aldehyde dehydrogenase, were upregulated by more than 2-fold. These results provide biochemical evidence that A. officinalis exerts biological functions including the alleviation of alcohol hangover and the protection of liver cells against toxic insults.

Moreover, eating instant asparagus powder had no effect on liver and kidney function. This was demonstrated in a small food study using 60 volunteers.

The dietary fiber and flavonoids of Asparagus officinalis improved the plasma lipid profile and reduced liver oxidative damage in a hypercholesterolemia mouse model.

Evidence strength: In vitro (cell culture) and animal models only. No controlled human trials have confirmed hepatoprotective effects of asparagus extracts specifically. The cell-culture study (Kim et al., 2009, PubMed ID 19895471) is frequently cited but is not a human clinical trial.

5.5 Lipid-Lowering (Hypolipidemic) Effects

Asparagus species contain bioactive constituents such as dietary fiber, polyphenols, saponins, sterols, oligosaccharides, carotenoids, and amino acids, all of which may contribute to the functional properties of this vegetable. Preclinical studies in rodents have demonstrated reductions in total cholesterol and LDL. Among the compounds with antioxidant activity, asparagus contains a large amount of polyphenols, mainly flavonoids.

Evidence strength: Primarily animal (rodent) studies. No human RCTs specifically on A. officinalis extracts for dyslipidemia are available in the literature reviewed.

5.6 Prebiotic and Digestive Effects

Evidence from human clinical studies suggests that inulin-type fructans (ITF, the class of prebiotic fibers found in asparagus) have a prebiotic effect on the intestinal microbiota, promoting the abundances of Bifidobacterium, Lactobacillus, and Faecalibacterium prausnitzii. Beneficial health effects reported following ITF intake include improved intestinal barrier function, improved laxation, increased insulin sensitivity, decreased triglycerides and an improved lipid profile, increased absorption of calcium and magnesium, and increased satiety.

Asparagus and its by-products' effect on human gut microbiota proliferation has been confirmed in vitro. A natural fructan obtained from asparagus roots was fermented in vitro by human fecal microbiota. The researchers observed a drop in the pH of the culture medium, coinciding with an increase in the content of SCFAs, particularly acetic, propionic, n-valeric acids, and i-valeric. They also observed significant changes in the microbiota composition after a 24-h incubation period: the genus Haemophilus decreased, while the beneficial genera Prevotella, Megamonas, and Bifidobacterium increased. These results indicated a health-promoting effect associated with the consumption of asparagus fructan.

Evidence strength: Moderate for inulin-type fructans as a class (supported by multiple human clinical trials); these trials used commercial inulin rather than asparagus-specific fructans. The asparagus-specific fructan data are in vitro. The broader ITF literature is more robust.

5.7 Sleep Quality

Huang (2017) found that instant asparagus powder not only could increase the effective sleep time of insomnia patients (from 5.1 h to 6.1 h), but also shorten the sleep latency (from 50.4 min to 25.3 min) through the food test of 60 volunteers.

Evidence strength: A single small human food study. This finding requires independent replication in a properly blinded, controlled trial before it can be considered reliable evidence.

5.8 Anticancer Effects

The chloroform fraction of A. officinalis exerted cytotoxic activity against breast cancer (MCF7), hepatocellular carcinoma (HEPG2), cervical cancer (HELA), and human normal melanocyte (HFB4) cell lines. The inedible bottom part of asparagus spears caused a concentration-dependent suppression of cell viability in breast, colon, and pancreatic cancers.

Treatment with asparagus officinalis also reduced ability of adhesion and invasion through epithelial–mesenchymal transition and reduction of VEGF expression in ovarian cancer cell lines. The combination of Asparagus officinalis with paclitaxel had synergistic anti-proliferative activity.

In vivo anticancer activity is desirable to confirm the in vitro findings. Asparaginase — an enzyme sourced from Asparagus officinalis — has been identified as a potent antileukemic agent.

Evidence strength: Preclinical only (cell lines and animal models). No clinical trials in humans have demonstrated anticancer effects for A. officinalis extracts as a supplement. The enzyme asparaginase, while derived from the genus, is a distinct pharmaceutical entity from dietary asparagus.

5.9 Anti-epileptic Effects

Antiepileptic effects of asparagus extracts have been reported in preclinical studies. The researchers also found that the ethanol extract of asparagus had multiple active effects, such as a good anti-epileptic effect.

Evidence strength: Animal/in vitro only. No human clinical data are available.

5.10 Eye Health (Cataract Prevention)

Animals were post-treated with oral solutions of A. officinalis extract at 200 mg/kg or 400 mg/kg once daily. Cataract grades were decreased considerably to 1.9 ± 0.72 and 1.5 ± 0.85 in groups that received 200 mg/kg and 400 mg/kg oral extract of A. officinalis, respectively. A. officinalis extract also restored all abnormalities of biochemical markers induced by sodium selenite. The data suggest that A. officinalis could be a promising candidate as a safe alternative treatment in cataracts upon further clinical trials. This effect is probably associated with the antioxidant activity of A. officinalis.

Evidence strength: Animal model only. No human trials have been conducted.

5.11 Reproductive and Hormonal Effects

In an animal study, groups of adult female Wistar rats received different doses (100, 200, 400 mg/kg/bw) of aqueous extract of asparagus roots, administered orally for 28 days. Dose-dependent aqueous extract of asparagus roots significantly increased serum levels of GnRH, FSH, LH, estrogen, and progestin hormones compared to control and sham groups. An increase in number of ovarian follicles and corpus luteum in groups treated with asparagus root extract was also observed. Despite medicinal application of asparagus for menstrual disorders in women, there is no evidence sufficient to support this claim.

Evidence strength: Animal only. Mechanistic plausibility from steroid saponin content; no human evidence.

6. Body Systems Associated with Asparagus

• Urinary/Renal: Diuretic actions; traditional use for kidney stones and urinary flow.
• Gastrointestinal: Prebiotic effects via inulin/FOS; fiber content supporting bowel regularity.
• Cardiovascular: Proposed ACE inhibition, rutin-mediated capillary support, and lipid-lowering effects (animal data).
• Hepatic: Antioxidant and enzyme-modulating effects demonstrated in cell and animal studies.
• Metabolic/Endocrine: Insulin-secretion–enhancing and glycemic-modulating effects in animal models.
• Neurological: Preliminary anti-epileptic and sleep-modulating observations.
• Immune/Oncological: Immunomodulatory, pro-apoptotic, and anti-proliferative activities in cell culture.
• Reproductive: Estrogenic and gonadotropin-modulating effects seen in animal experiments.
• Ocular: Antioxidant-mediated protection against lens opacification in animal models.
• Skin: Traditional topical application for acne; limited scientific evidence.

7. Dosage Forms and Reported Dosages

The following dosages are reported strictly as used in cited sources and do not imply recommended clinical doses.

• Asparagus-P tablets (dried asparagus root + parsley): 4 tablets 3 times/day (maximum of 2,400 mg daily of dried asparagus root) for 6 weeks was evaluated for antihypertensive effects; adverse reactions led to participant withdrawal from the study.
• Seed extract in animal studies: 250 mg/kg and 500 mg/kg per day for 28 days; a dose-dependent improvement was found for the 500 mg/kg dose, which was associated with an increase in insulin secretion.
• Aqueous extract of by-products in animal studies: Supplementation for 21 days significantly decreased serum glucose and triglyceride concentrations in diabetic rats.
• Oral solutions for cataract study (neonatal rats): 200 mg/kg or 400 mg/kg once daily on days 10–16 postnatal.
• Aqueous root extract in adult rats: 100, 200, and 400 mg/kg/bw administered orally for 28 days.
• General clinical dosing: There is insufficient clinical evidence to provide dosing recommendations for asparagus.

8. Safety Considerations and Drug Interactions

8.1 GRAS Status and General Safety

Asparagus has "generally recognized as safe" (GRAS) status when used as food. Dosages above those found in food should be avoided because safety and efficacy have not been established.

8.2 Allergic Reactions

Symptoms of allergy to asparagus, including rhinitis, occupational asthma, oral allergic syndrome, allergic contact dermatitis, and anaphylaxis, are well documented. Asparagus might cause an allergic reaction in people who are sensitive to other members of the Liliaceae family including onions, leeks, garlic, and chives.

Additional documented cutaneous reactions include: asparagus-induced fixed food eruptions mimicking cutaneous lupus, reported in the dermatological literature (Acta Derm Venereol 2014).

8.3 Gout

Exacerbation of gout has been reported with excessive consumption.

8.4 Pregnancy and Lactation

Asparagus is considered unsafe to use in medicinal amounts during pregnancy. Asparagus extracts have been used for birth control, so they might harm hormone balances during pregnancy. Not enough is known about the safety of using asparagus in medicinal amounts during breast-feeding. It is best to stick to food amounts.

8.5 Drug Interactions

Regarding lithium, the interaction is rated as moderate. Asparagus might have an effect like a water pill or "diuretic." Taking asparagus might decrease how well the body gets rid of lithium.

No other drug interactions are well documented for asparagus.

8.6 Urinary Odor

Asparagus contains asparagusic acid, an odorless sulfurous compound that is metabolized in the body into sulfur-containing compounds such as methanethiol and dimethyl sulfide. Not all people produce this smell, and people also vary in their ability to detect it.

9. Summary of Evidence Quality

Asparagus has been studied for its diuretic, hypoglycemic, antihypertensive, hypocholesterolemic, CNS, and antioxidant effects; however, there is little to no clinical evidence to support these uses. Other species, such as Asparagus racemosus, have been used in traditional Chinese and Ayurvedic medicine but are distinct from A. officinalis. There is insufficient clinical evidence to provide dosing recommendations for asparagus.

Studies have claimed that Asparagus officinalis L. has pharmacological effects such as anti-fatigue effects, enhanced anoxia tolerance, induced analgesia, and improved memory, as well as decreased contents of lipid peroxide in plasma, liver, and brains of rats. However, this was not linked to the active compound present from the plant that could be responsible for those pharmacological activities.

The richness of documented bioactive compounds in A. officinalis — including rutin, protodioscin, asparagosides, inulin-type fructans, and numerous phenolics — provides plausible mechanistic rationale for many of its traditional and proposed modern uses. However, the preponderance of current evidence derives from in vitro cell culture or rodent models, and the translation of these findings to human therapeutic applications remains largely unconfirmed by adequately powered, controlled clinical trials.

References

• Olas B. A Review of the Pro-Health Activity of Asparagus officinalis L. and Its Components. Foods. 2024;13(2):288. PMC10814860
• Negi JS, et al. Chemical constituents of Asparagus. Pharmacognosy Reviews. PMC3249924
• Subramanian S, et al. Green and White Asparagus (Asparagus officinalis): A Source of Developmental, Chemical and Urinary Intrigue. Molecules. PMC7022954
• Kim BY, et al. Effects of Asparagus officinalis Extracts on Liver Cell Toxicity and Ethanol Metabolism. J Food Sci. 2009. PubMed PMID 19895471
• Hafizur RM, Kabir N, Chishti S. Asparagus officinalis extract controls blood glucose by improving insulin secretion and β-cell function in streptozotocin-induced type 2 diabetic rats. Br J Nutr. 2012;108(9):1586–95. PubMed PMID 22221560
• Jaramillo-Flores ME, et al. Identification of Six Phytochemical Compounds from Asparagus officinalis L. Root Cultivars Using UAE-SPE-UPLC-MS/MS. PMC6356627
• Vazquez-Castilla S, et al. Bioactive Constituents from "Triguero" Asparagus Improve the Plasma Lipid Profile and Liver Antioxidant Status in Hypercholesterolemic Rats. Int J Mol Sci. 2013;14:21227–21239. PMC3856001
• Jiménez-Sánchez C, et al. Identification of Bioactive Compounds of Asparagus officinalis L. Molecules. 2021;26(6):1640. PMC7999721
• Fujioka S, et al. Distribution of Rutin and Protodioscin in Different Tissue Parts of Asparagus (Asparagus officinalis L.). HortScience. 2019;54(11)
• Fujioka S, et al. Transcriptome analysis of Asparagus officinalis reveals genes involved in the biosynthesis of rutin and protodioscin. DNA Res. 2019. PMC6645489
• Shokoohi M, et al. The Preventive Effects of Asparagus officinalis Extract on Sodium Selenite-Induced Cataractogenesis in Experimental Animal Models. PMC7704146
• Xu G, et al. Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer. Front Oncol. 2021. PMC8317209
• Frontiers in Pharmacology. Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer. 2024.
• Madrigal-Santillán E, et al. The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review. PMC8970830
• Hamdi M, et al. Asparagus Fructans as Emerging Prebiotics. PMC9818401
• Literature analysis on asparagus roots and review of its functional characterizations. Front Nutr. 2022. PMC10149932
• Guo Y, et al. The bioactive compounds and biological functions of Asparagus officinalis L. – A review. J Funct Foods. 2020.
• Effects of aqueous extract from Asparagus officinalis L. roots on hypothalamic-pituitary-gonadal axis hormone levels and the number of ovarian follicles in adult rats. PMC4869160
• Drugs.com Natural Product Monograph: Asparagus (Asparagus officinalis). Updated October 2025.
• Plants of the World Online — Kew Science: Asparagus officinalis L.
• Hektoen International: Asparagus in history and medicine.
• Okem A, et al. Medicinal Properties of Selected Asparagus Species: A Review. IntechOpen. 2019.
• Frontiers in Nutrition: Asparagus officinalis potentially supports cancer care: a systematic review of randomized and non-randomized clinical studies. 2026.
• Hamdi M, et al. Nutritional composition of green asparagus (Asparagus officinalis L.), edible part and by-products, and assessment of their effect on the growth of human gut-associated bacteria. Food Res Int. 2023;163:112284.
• Differential effects of inulin and fructooligosaccharides on gut microbiota composition and glycemic metabolism in overweight/obese and healthy individuals. PMC12219383